What pharmacists can do
- Ensure that any woman of reproductive age prescribed valproate is counselled about the associated risks in pregnancy, and how to access advice regarding alternative treatments. The application of MHRA’s policy on valproate would be appropriate.
- Advise adherence with current regime pending specialist review
